Publications by authors named "Benjamin M Wohl"

Claim this Profile
P
Polyanionic Macromolecular Prodrugs of Ribavirin: Antiviral Agents with a Broad Spectrum of Activity.
Tracey M Hinton, Kaja Zuwala, Celine Deffrasnes, Shawn Todd, Shuning Shi, Benjamin M Wohl

Adv Healthc Mater· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tools of gene transfer applied to the intracellular delivery of non-nucleic acid polyanionic drugs.
Mille B L Kryger, Søren L Pedersen, Benjamin M Wohl, Alexander N Zelikin

Chem Commun (Camb)· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly active macromolecular prodrugs inhibit expression of the hepatitis C virus genome in the host cells.
Pau Ruiz-Sanchis, Benjamin M Wohl, Anton A A Smith, Kaja Zuwala, Jesper Melchjorsen

Adv Healthc Mater· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macromolecular prodrugs of ribavirin: towards a treatment for co-infection with HIV and HCV.
Anton A A Smith, Kaja Zuwala, Mille B L Kryger, Benjamin M Wohl, Carlos Guerrero-Sanchez

Chem Sci· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disulfide reshuffling triggers the release of a thiol-free anti-HIV agent to make up fast-acting, potent macromolecular prodrugs.
Anders Kock, Kaja Zuwala, Anton A A Smith, Pau Ruiz-Sanchis, Benjamin M Wohl

Chem Commun (Camb)· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macromolecular (pro)drugs with concurrent direct activity against the hepatitis C virus and inflammation.
Benjamin M Wohl, Anton A A Smith, Bettina E B Jensen, Alexander N Zelikin

J Control Release· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macromolecular prodrugs of ribavirin: concerted efforts of the carrier and the drug.
Anton A A Smith, Benjamin M Wohl, Mille B L Kryger, Natasha Hedemann, Carlos Guerrero-Sanchez

Adv Healthc Mater· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macromolecular prodrugs for controlled delivery of ribavirin.
Mille B L Kryger, Anton A A Smith, Benjamin M Wohl, Alexander N Zelikin

Macromol Biosci· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Narrow therapeutic window of ribavirin as an inhibitor of nitric oxide synthesis is broadened by macromolecular prodrugs.
Benjamin M Wohl, Anton A A Smith, Mille B L Kryger, Alexander N Zelikin

Biomacromolecules· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly(vinyl alcohol) physical hydrogel nanoparticles, not polymer solutions, exert inhibition of nitric oxide synthesis in cultured macrophages.
Sidsel Ø Andreasen, Siow-Feng Chong, Benjamin M Wohl, Kenneth N Goldie, Alexander N Zelikin

Biomacromolecules· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macromolecular prodrugs of ribavirin combat side effects and toxicity with no loss of activity of the drug.
Mille B L Kryger, Benjamin M Wohl, Anton A A Smith, Alexander N Zelikin

Chem Commun (Camb)· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responsive layer-by-layer materials for drug delivery.
Benjamin M Wohl, Johan F J Engbersen

J Control Release· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis